Skip to main content
. 2024 Jul 23;16:163. doi: 10.1186/s13195-024-01530-8

Table 1.

Baseline population characteristics according to the baseline level of exposure to anticholinergic and sedative drugs

Baseline DBI level: No exposure
n = 314
Moderate exposure
n = 1339
High exposure
n = 317
Total
n = 1970
n (%) or mean ± sd p-value n (%) or mean ± sd
Sex
 Female 179 (57.0) 814 (60.8) 202 (63.7) 0.222 1195 (60.7)
Age (years) 79.8 ± 7.9 79.8 ± 7.1 78.8 ± 7.4 0.076 79.6 ± 7.3
Educational level n = 1,862 0.001
 None 46 (15.3) 191 (15.1) 68 (22.8) 305 (15.5)
 Primary 79 (26.2) 414 (32.8) 94 (31.5) 587 (29.8)
 Secondary and further 176 (58.5) 658 (52.1) 136 (45.6) 970 (49.3)
IADL (/8) n = 1,927 4.8 ± 2.3 4.5 ± 2.4 4.0 ± 2.4  < 0.001 4.5 ± 2.4
NPI (/144) n = 1,522 16.2 ± 15.0 19.9 ± 16.1 23.8 ± 19.1  < 0.001 20.0 ± 16.6
Anxiety disorders n = 1,887 5 (1.7) 27 (2.1) 7 (2.3) 0.851 39 (2.0)
Depressive disorders n = 1,887 4 (1.3) 32 (2.5) 21 (7.0)  < 0.001 57 (2.9)
MMSE (/30) 21.6 ± 5.5 21.1 ± 5.6 20.5 ± 5.9 0.037 21.1 ± 5.7

DBI Drug Burden Index, IADL Instrumental Activities of Daily Living score, MMSE Mini Mental State Examination, NPI Neuropsychiatric Inventory score